Cannabis Research

Using Brewer’s Yeast to Scale the Production of Minor Cannabinoids

mm
Add MyCannabis.com to your preferred sources on Google

Minor cannabinoids have shown promising therapeutic potential, but their naturally low concentrations in cannabis make extraction costly and inefficient. Now, researchers are exploring whether brewer’s yeast can serve as a biofactory to produce these rare compounds at scale, reducing costs and environmental impact.

Environmental Challenges of Traditional Cannabis Cultivation

The cultivation of cannabis, especially in indoor and greenhouse settings, is highly resource-intensive. Studies1 have found that large-scale operations contribute significantly to electricity consumption and environmental degradation. For instance, in California, cannabis production accounts for about 3% of total electricity use. This energy is consumed by grow lights, fans, and climate control systems, alongside the environmental impact of chemical fertilizers that can leach into waterways.

Given these challenges, scientists are seeking greener, more efficient methods to produce cannabinoids without the environmental footprint of traditional cultivation.

Why Focus on Minor Cannabinoids?

Beyond THC and CBD, cannabis contains over 100 other cannabinoids, most of which occur in very small amounts. These “minor cannabinoids” are increasingly studied for their potential medical benefits, but are difficult and expensive to extract from plants due to their low concentrations.

Brewer’s Yeast as a Biofactory

Jay Keasling, a pioneer in synthetic biology, has explored using yeast as a “green drug factory.” Researchers at the University of California, Berkeley, have bioengineered brewer’s yeast to produce rare cannabinoids that are almost impossible to extract naturally at scale. This research2, reported by ScienceDaily, demonstrates that yeast-based production can deliver high-quality cannabinoids at a fraction of the cost and with minimal contamination risk.

Other Biotech Successes with Yeast

Yeast has long been used in biotechnology to produce complex molecules, including insulin, blood clotting factors, growth hormones, and the antimalarial drug artemisinin. This track record makes it an ideal candidate for cannabinoid biosynthesis.

How Yeast Produces Cannabinoids

The UC Berkeley team inserted cannabis sativa and Streptomyces spp. genes into yeast using a heterologous expression system to produce phytocannabinoid precursors. The process includes:

  • Condensing hexanoic acid with malonic acid to produce olivetolic acid (OA)
  • Alkylating OA with geranyl pyrophosphate (GPP) to form cannabigerolic acid (CBGA)
  • Using specific enzymes to convert CBGA into minor cannabinoids like cannabidivarin (CBDV) and tetrahydrocannabivarin (THCV)

These compounds can then be isolated for research and potential therapeutic use.

Swipe to scroll →
Production Method Traditional Cannabis Extraction Brewer’s Yeast Biosynthesis
Source Material Cannabis plants grown in greenhouses or indoors Bioengineered yeast cultures
Environmental Impact High energy use, chemical fertilizer runoff Low energy footprint, minimal chemical use
Cost Efficiency High for minor cannabinoids Competitive or lower than plant extraction
Scalability Limited by cultivation capacity Easily scalable in fermentation tanks
Purity and Consistency Variable due to plant genetics and environment High purity, consistent yields

Challenges and Future Potential

While the method shows great promise, related research by Schmidt and Kayser highlights a bottleneck: the production of hexanoic acid in yeast can limit yields. Overcoming this challenge will be key to scaling production further. Still, the environmental, economic, and scalability benefits make yeast biosynthesis a strong candidate for industrial cannabinoid production.

As research into minor cannabinoids continues, sustainable production methods like yeast biosynthesis could play a vital role in meeting future demand for pharmaceutical and wellness applications.

References:

1. Zheng, Z., Fiddes, K. & Yang, L. A narrative review on environmental impacts of cannabis cultivation. J Cannabis Res 3, 35 (2021). https://doi.org/10.1186/s42238-021-00090-0
2. University of California – Berkeley. (2019, February 27). Yeast produce low-cost, high-quality cannabinoids. ScienceDaily.

Lydia K. (Bsc. RN) is a cannabis writer, which, considering where you’re reading this, makes perfect sense. Currently, she is a regular writer for Mace Media. In the past, she has written for MyBud, RX Leaf & Dine Magazine (Canada), CBDShopy (UK) and Cannavalate & Pharmadiol (Australia). She is best known for writing epic news articles and medical pieces. Occasionally, she deviates from news and science and creates humorous articles. And boy doesn't she love that! She equally enjoys ice cream, as should all right-thinking people.